Written Question·Department of Health and Social Care·UIN 8825
Aldesleukin
Tabled: 14 October 2024
Answered: 23 October 2024
Question
Jim Shannon
Democratic Unionist Party — Strangford
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the viability of aldesleukin as a routine treatment for people who have had a heart attack.
Answer
The National Institute for Health and Care Research (NIHR) Cambridge Biomedical Research Centre and the NIHR Cambridge Clinical Research Facility are supporting research into the benefits of low doses of aldesleukin for people who have experienced a heart...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 8825) →